Liraglutide vs insulin glargine and placebo in combination with metformin and sulfonylurea therapy in type 2 diabetes mellitus (LEAD-5 met+SU): a randomised controlled trial

2009827 citationsJournal Articlehybrid Open Access

Authors

The study was funded by Novo Nordisk A/S.

Good health and well-being

Published in: Diabetologia

Volume 52, Issue 10, pp. 2046-2055

Field-Weighted Citation Impact: 64.00